tongue cancer Genome/Transcriptome Sequencing Project Promises PGx Strategy for Rare Cancers Premium A recent study combined analysis of a patient's tumor genome and transcriptome sequences to guide treatment of tongue adenocarcinoma with Pfizer's Sutent (sunitinib) and Bayer's Nexavar (sorafenib). Breaking News In Brief This Week: Qiagen, Devyser Diagnostics, Sequential Skin, Amili, TruDiagnostic Tempus, IFLI Partner to Accelerate Development of Follicular Lymphoma Therapies GenomOncology, Pillar Biosciences Partner to Develop NGS-Driven Clinical Decision Support Solution Latent Labs Emerges From Stealth With $50M in Funding for AI-Powered Protein Design QuidelOrtho Q4 Revenues Dip 5 Percent, Beat Estimates
